Stocktoria

Balance Labs, Inc. BLNC

OTC · stock · Services-Management Consulting Services · website · IPO 2015-10-20

Balance Labs, Inc. financials (annual)

Revenue
$500 $6667 $3333 $1.0M $624590 $247500 $6000 2016201720182019202020212022202320242025
Net income
-$1.1M -$837190 -$547678 -$884217 $357757 -$796696 -$768351 -$381571 -$528223 -$31.8M 2016201720182019202020212022202320242025
Free cash flow
-$645053 -$424441 -$66396 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$6,000——$247,500$624,590$1.0M$3,333$6,667$500—
Gross profit$6,000—————————
Operating income-$13.1M-$271,285-$116,300-$22,836$224,426$612,506-$557,942-$603,055-$533,609-$670,033
Interest expense——$224,375$231,671$244,291$205,838$167,087$129,908$304,468—
Net income-$31.8M-$528,223-$381,571-$768,351-$796,696$357,757-$884,217-$547,678-$837,190-$1.1M
EPS (diluted)$-1.23$-0.02$-0.02$0.04$0.04$0.02$-0.04———
Operating cash flow-$257,024-$157,110-$122,502$7,753-$56,896-$218,002-$365,608-$420,269-$372,332-$635,073
Free cash flow————-$66,396——-$424,441—-$645,053
Cash & equivalents$358,975$13,199$112,809$235,311$227,558$5,632$9,184$27,223——
Total assets$397,506$95,575$220,721$429,119$1.0M$1.3M$237,421$314,864$121,402$955,233
Total liabilities$3.8M$5.2M$4.8M$4.6M$4.4M$3.9M$3.2M$2.4M$1.6M—
Shareholders' equity-$3.4M-$5.1M-$4.5M-$4.2M-$3.4M-$2.6M-$2.9M-$2.1M-$1.5M$126,181

Growth · year-over-year · Revenue CAGR 51.3%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth———-60.4%-37.5%+29903.0%-50.0%+1233.4%——
Net income growth————-322.7%—————
EPS growth——-150.0%+0.0%+100.0%—————

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.